Professor Ian Wong

Professor Ian Wong

Professor Ian Wong is an alumnus of University of Manchester [MSc (1996) and PhD (1998)]. He is currently the Head of Department of Pharmacology and Pharmacy, University of Hong Kong. He is also the holder of Lo Shiu Kwan Kan Po Ling Endowed Professorship in Pharmacy.

As an academic pharmacist with expertise in pharmacoepidemiology and big data research, specifically in neuropsychopharmacology. Professor Wong has over 250 publications with publication in JAMA, JAMA Internal Medicine, JAMA Psychiatry, Lancet Psychiatry, Lancet Infectious Disease, BMJ.  According to Clarivate Analytics' Essential Science Indicators, Professor Wong has been a top 1% scholar in 2015 to 2018.

Professor Wong received the Chemist and Druggist's Pharmacy Practice Research Medal in 2004 for his research in paediatric medicines. In recognition of his work in paediatric medicines research, Professor Wong was awarded an Honorary Fellowship of the Royal College of Paediatrics and Child Health in 2011, and Fellowship of the Royal Pharmaceutical Society in 2012. He was the coordinator of the ADDUCE consortium which was funded by the European Commission to evaluate the long-term safety of methylphenidate. He was a member of the NICE ADHD guideline development group in 2009 and 2018 respectively.

In 2006, Professor Wong set up a UCL spin-off company with Great Ormond Street Hospital for Children (Therakind), a paediatric healthcare company, that creates, develops, and improves paediatric and other specialty medicinal products. It develops Buccolam®, a treatment for prolonged acute convulsive seizures in children; Ayendi®, an intranasal paediatric pain control product; and Jylamvo®, an oral syrup for juvenile idiopathic arthritis.